摘要
目的 分析血清C肽与糖化血红蛋白联合检验诊断糖尿病的价值。方法 将2021年1—12月江苏省沭阳县中医院接诊的43例糖尿病患者作为观察组,将同期的43名健康体检者作为对照组,对两组进行血清C肽与糖化血红蛋白联合诊断,并比较血糖相关指标。结果 与对照组相比,观察组的空腹血糖、餐后2 h血糖以及糖化血红蛋白水平更高,血清C肽水平更低,差异有统计学意义(P<0.05)。结论 糖尿病患者与健康者在多项血糖指标上差异明显,经血清C肽与糖化血红蛋白联合检验可予以明确区分,临床诊断价值非常显著。
Objective To analyze the value of combined test of serum C-peptide and glycosylated hemoglobin in the diagnosis of diabetes.Methods A total of 43 diabetic patients admitted to Shuyang County Traditional Chinese Medicine Hospital of Jiangsu Province from January to December 2021 were selected as the observation group.The 43healthy people who underwent physical examination during the same period were selected as the control group.Combined diagnosis of serum C-peptide and glycosylated hemoglobin was performed in the two groups,and differences in blood glucose-related indicators were compared.Results Compared with the control group,the levels of fasting blood glucose,2 h postprandial blood glucose and glycosylated hemoglobin in the observation group were higher,while the serum C-peptide level was lower,and the difference was statistically significant(P<0.05).Conclusion Diabetic patients and healthy people have obvious differences in many blood glucose indicators,which can be clearly distinguished by the combined test of serum C-peptide and glycosylated hemoglobin,and the clinical diagnostic value is very significant.
作者
伍广
徐守阳
陈睿
WU Guang;XU Shouyang;CHEN Rui(Department of Laboratory Medicine,Shuyang County Hospital of Traditional Chinese Medicine,Suqian,Jiangsu Province,223600 China)
出处
《糖尿病新世界》
2022年第17期72-74,78,共4页
Diabetes New World Magazine
